These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19107674)

  • 1. Ets-1 is increased in anticancer drug-containing media and hypoxic cultures, similar to TACE.
    Mamori S; Tajiri H
    Scand J Gastroenterol; 2009; 44(4):507-8. PubMed ID: 19107674
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL.
    Chang WT; Hsieh BS; Cheng HL; Lee KT; Chang KL
    J Surg Res; 2014 May; 188(2):432-41. PubMed ID: 24594218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.
    Tavernier J; Fagnoni P; Chabrot P; Guiu B; Vadot L; Aho S; Boyer L; Abergel A; Hillon P; Sautou V; Boulin M
    Anticancer Res; 2014 Dec; 34(12):7247-53. PubMed ID: 25503156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
    J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Hsieh MY; Lin ZY; Chen SH; Chuang WL
    Kaohsiung J Med Sci; 2011 Oct; 27(10):431-6. PubMed ID: 21943814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
    Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
    Lin ZY; Chuang WL; Chuang YH; Yu ML; Hsieh MY; Wang LY; Tsai JF
    J Gastroenterol Hepatol; 2006 Feb; 21(2):398-405. PubMed ID: 16509865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pharmacokinetics in patients treated with transarterial chemoembolization (TACE) using two types of epirubicin-loaded microspheres.
    Sottani C; Poggi G; Quaretti P; Regazzi M; Montagna B; Quaquarini E; Imbriani M; Leoni E; Di Cesare P; Riccardi A; Bernardo G; Minoia C
    Anticancer Res; 2012 May; 32(5):1769-74. PubMed ID: 22593459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma.
    Pohl J; Zuna I; Stremmel W; Rudi J
    Chemotherapy; 2001; 47(5):359-65. PubMed ID: 11561139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of hepatocellular carcinoma effectively treated with epirubicin aqueous vesicles in monodispersed iodized poppy-seed oil microdroplets.
    Higashi S; Maeda Y; Kai M; Kitamura T; Tsubouchi H; Tamura S; Setoguchi T
    Hepatogastroenterology; 1996; 43(12):1427-30. PubMed ID: 8975943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin].
    Kawamura Y; Ikeda K; Kumada H
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):402-7. PubMed ID: 20332675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.
    Mao G; Yu Z; Zhang Y; Cheng J
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):391-3. PubMed ID: 12408773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
    Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
    Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.